News & Updates

Deep brain stimulation safe, feasible for poststroke rehabilitation

24 Sep 2023 by

Using deep brain stimulation (DBS) to target the cerebellar dentate nucleus appears to be a promising approach for treating patients with poststroke motor impairment, with a first-in-human trial showing that the intervention is safe and yields meaningful improvements in motor function when combined with physical therapy.

Deep brain stimulation safe, feasible for poststroke rehabilitation

24 Sep 2023

Anticoagulation during CKRT reduces dialysis, death in AKI patients

24 Sep 2023 by

Use of anticoagulants during continuous kidney replacement therapy (CKRT) helps lower dialysis dependence and prevent death at 90 days among critically ill patients with acute kidney injury (AKI) following admission to the intensive care unit (ICU), a study in Singapore has shown.

Anticoagulation during CKRT reduces dialysis, death in AKI patients

24 Sep 2023

Folic acid helps improve sexual function of postmenopausal women

24 Sep 2023

Folic acid appears beneficial in improving sexual function among postmenopausal women, suggests a recent study. However, further research is needed to validate this finding.

Folic acid helps improve sexual function of postmenopausal women

24 Sep 2023

Several factors must be considered when tapering adalimumab in noninfectious uveitis patients

24 Sep 2023

For patients who undergo adalimumab tapering after achieving remission, factors such as age, race, and duration of disease remission on adalimumab appear to impact the risk of relapse, according to a study.

Several factors must be considered when tapering adalimumab in noninfectious uveitis patients

24 Sep 2023

Tirzepatide a valuable therapeutic option for weight management

23 Sep 2023

Treatment with tirzepatide, a dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist approved for type 2 diabetes, leads to substantial reductions in weight despite an increase in gastrointestinal symptoms, according to the results of a meta-analysis.

Tirzepatide a valuable therapeutic option for weight management

23 Sep 2023

Real-world data affirm effectiveness of vacuum-controlled device for obstetric bleeding

23 Sep 2023 by

The FDA-approved intrauterine vacuum-induced haemorrhage-control device rapidly controls bleeding in both vaginal and caesarean births, with a safety profile consistent with that observed in the registrational trial, as shown in a postmarket registry medical record review study.

Real-world data affirm effectiveness of vacuum-controlled device for obstetric bleeding

23 Sep 2023

Depression, diabetes duration predict sexual dysfunction in women with T1D

23 Sep 2023

Type 1 diabetes (T1D) is significantly associated with the risk of sexual dysfunction among women, according to the results of a systematic review and meta-analysis.

Depression, diabetes duration predict sexual dysfunction in women with T1D

23 Sep 2023

Vaping tied to chronic stress, poor QoL in young adults

23 Sep 2023 by

Use of e-cigarette (EC) shows a significant relation with a higher incidence of chronic stress and is indicative of poorer quality of life (QoL) in young adults, suggests a study presented at ERS 2023.

Vaping tied to chronic stress, poor QoL in young adults

23 Sep 2023

$3-vessel CAD outcomes comparable with fractional flow reserve-guided PCI vs CABG$

3-vessel CAD outcomes comparable with fractional flow reserve-guided PCI vs CABG

23 Sep 2023

In the treatment of patients with 3-vessel coronary artery disease (CAD), fractional flow reserve (FFR)-guided percutaneous coronary intervention (PCI) does not differ from coronary artery bypass grafting (CABG) in terms of the incidence of the composite of death, myocardial infarction (MI), or stroke, according to 3-year data from the FAME 3* trial.

3-vessel CAD outcomes comparable with fractional flow reserve-guided PCI vs CABG

23 Sep 2023

Fatigue in COPD influenced by multiple contributing factors

22 Sep 2023 by

Fatigue in people with chronic obstructive pulmonary disease (COPD) may be caused by factors such as shortness of breath, sleep quality, pain, and fatigue-related catastrophizing, according to the FAntasTIGUE study.

Fatigue in COPD influenced by multiple contributing factors

22 Sep 2023

News & Updates

Filter by Specialty:

Specialty:

Deep brain stimulation safe, feasible for poststroke rehabilitation

Deep brain stimulation safe, feasible for poststroke rehabilitation

Anticoagulation during CKRT reduces dialysis, death in AKI patients

Anticoagulation during CKRT reduces dialysis, death in AKI patients

Folic acid helps improve sexual function of postmenopausal women

Folic acid helps improve sexual function of postmenopausal women

Several factors must be considered when tapering adalimumab in noninfectious uveitis patients

Several factors must be considered when tapering adalimumab in noninfectious uveitis patients

Tirzepatide a valuable therapeutic option for weight management

Tirzepatide a valuable therapeutic option for weight management

Real-world data affirm effectiveness of vacuum-controlled device for obstetric bleeding

Real-world data affirm effectiveness of vacuum-controlled device for obstetric bleeding

Depression, diabetes duration predict sexual dysfunction in women with T1D

Depression, diabetes duration predict sexual dysfunction in women with T1D

Vaping tied to chronic stress, poor QoL in young adults

Vaping tied to chronic stress, poor QoL in young adults

3-vessel CAD outcomes comparable with fractional flow reserve-guided PCI vs CABG

3-vessel CAD outcomes comparable with fractional flow reserve-guided PCI vs CABG

Fatigue in COPD influenced by multiple contributing factors

Fatigue in COPD influenced by multiple contributing factors